V-Link Luer-Activated Device with VitalShield Protective Coating

The V-Link device with VitalShield protective coating kills on average 99.9% or more of specific common pathogens known to cause catheter-related bloodstream infections (CR-BSIs):**

• Fights pathogen contamination and microbial growth in the fluid path
• Consistently high efficacy across multiple bacterial strains¹
• Demonstrated durability and efficacy over 96 hours¹

 

* The antimicrobial agent is not intended to be used as a treatment for existing infections.

** These in vitro test results have not been shown to correlate with a reduction in infections.

Every day, you do all you can to fight against microbial contamination. Proper aseptic technique at the IV insertion site can reduce extraluminal contamination (outside the catheter walls).

 

Study results by Safdar and Maki concluded that after specific preventive measures were used to address contamination at the insertion site, 60% of CR-BSIs were more likely to originate from the intraluminal pathway.²

 

- Technology to help protect the intraluminal pathway (the fluid path) is also needed to further reduce the risk of CR-BSIs.

 

Contraindication
The V-Link device is contraindicated for individuals with hypersensitivity to silver or silver components.

 

Rx only
For safe and proper use of this device, please refer to the complete instructions for use.

 

¹ Data on file, Baxter Healthcare Corporation
² Safdar N, Maki DG. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med. 2004;30:62-67.